Be the first to like this
In Western Europe (EU-16) countries major portion of healthcare is borne by the government. These Western Europe (EU-16) countries spend 9 to 11% of their GDP on the healthcare of its citizens. So the recent Euro zone crisis has hardly hit the In Vitro Diagnostics (IVD) market for the year 2011 and 2012. But from 2013 the growth for In Vitro Diagnostics (IVD) industry is expected to be back on track. Western Europe (EU-16) In Vitro Diagnostics (IVD) market is one of the biggest markets globally. Western Europe (EU-16) In Vitro Diagnostics (IVD) market is expected to be more than Euro 11 Billion by 2015.
Germany, France and Italy are three biggest markets in Western European (EU-16) countries. Germany controls the biggest market share closely followed by France and Italy in 2011. Together these three countries controls 58.5% market share for the year 2011. From our research we found that only two countries out of 16 countries studied in this report is expected to show a contraction in In Vitro Diagnostics (IVD) market for the year 2012. Whereas rest of the Western Europe (EU-16) countries will either grow marginal or will show no growth for the year 2012. However from 2013 every country is expected to back on track and expected to grow.
Click here to view the report details: http://www.renub.com/report/western-europe-eu-16-in-vitro-diagnostics-market-report-forecast-2012---2015-84
Sr. Manager - Publisher Relation
Sales & Marketing Div.
Phone: +1-678-302-0700 (USA) , +91-120-4219-822, +91-120-254-5750 (India)